Anti-cancer immunotherapy: breakthroughs and future strategies

Semin Immunopathol. 2019 Jan;41(1):1-3. doi: 10.1007/s00281-018-0711-z. Epub 2018 Sep 21.

Author

Mads Hald Andersen^{1

2}

Affiliations

¹ Center for Cancer Immune Therapy (CCIT), Department of Hematology, Copenhagen University Hospital, Herlev, DK-2730, Herlev, Denmark. mads.hald.andersen@regionh.dk.
² Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark. mads.hald.andersen@regionh.dk.

PMID: 30242450
DOI: 10.1007/s00281-018-0711-z

No abstract available

Publication types

Editorial

MeSH terms

Biomarkers, Tumor
Humans
Immunotherapy* / adverse effects
Immunotherapy* / methods
Molecular Targeted Therapy
Neoplasms / etiology
Neoplasms / immunology*
Neoplasms / therapy*

Substances

Biomarkers, Tumor